Geneva, March 23 -- International Clinical Trials Registry received information related to the study (KCT0011672) titled 'Effect of inhaled Mucomyst and Hypertonic saline in Bronchiectasis' on March 3.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Cross-over, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Ulsan Univeristy Hospital
Condition:
Diseases of the respiratory system
Intervention:
Drug : In this study, patients with bronchiectasis who exhibit daily sputum symptoms and visit the outpatient respiratory clinic will be randomly assigned to a control group (receiving distilled water nebulizer treatment) or an experimental group (receiving Mucomyst [10% NAC] combin...